Cambridge Investment Research Advisors, Inc.
Position in GALT — Galectin Therapeutics Inc
CIK 1419186
FAIRFIELD, IA
Position in GALT
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$606,206
+$247,279 QoQ
Shares Held
130,648
+1.6% QoQ
Ownership
0.130%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 98 holders
Holding Since
Mar 2020
25 quarters on record
Common Shares in GALT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cambridge Investment Research Advisors, Inc. holds $60,632,692 across 72 Biotechnology names. GALT ranks #26 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
21,946 | $10,901,236 | |
| 2 | EXEL |
Exelixis, Inc.
|
82,212 | $4,473,154 | |
| 3 | NKTR |
Nektar Therapeutics
|
56,186 | $3,922,344 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
35,157 | $3,056,901 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
15,839 | $2,966,327 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,591 | $2,862,672 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
46,210 | $2,520,293 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
30,727 | $2,288,546 |
All Filings in GALT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $606,206 | 130,648 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $358,927 | 128,648 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $524,239 | 126,019 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $513,904 | 121,204 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $255,974 | 121,315 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $144,673 | 118,585 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $152,974 | 118,585 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $315,480 | 114,720 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $253,413 | 112,130 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $289,526 | 121,141 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $210,124 | 126,581 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $265,290 | 138,172 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $193,438 | 134,332 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $299,046 | 142,403 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $171,275 | 151,571 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $245,577 | 150,661 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $194,848 | 148,739 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $233,783 | 145,207 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $316,765 | 153,027 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $638,252 | 164,498 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $538,611 | 168,316 | Shares | Sole | 2021-08-10 | |
| 2020-12-31 | $402,205 | 179,556 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $510,490 | 191,195 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $620,956 | 202,927 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $401,455 | 204,824 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||